Mounjaro 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FN4QB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,265
Award facts
- Contract value 100% obligated
- $3,265.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 24, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors, with a ceiling value of $3,265.08. This is a firm fixed-price, non-competitive set-aside delivery order with an ultimate completion date of September 25, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999 and extends through December 2026.
Mounjaro is a diabetes medication used for glycemic control and weight management in patients with type 2 diabetes. AmerisourceBergen is a major pharmaceutical distributor and critical federal healthcare vendor that supplies a comprehensive range of medications, vaccines, and medical devices to support military and veteran healthcare systems. The DLA Medical Supply Chain utilizes AmerisourceBergen's pharmaceutical prime vendor contract to ensure consistent availability of essential medications across the Defense Health Agency and other federal healthcare customers. This delivery order aligns with the company's ongoing role as a primary pharmaceutical supplier within the DLA's global medical support operations.
Quick answers
Who was awarded contract SPE2DB25FN4QB?
SPE2DB25FN4QB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 24, 2025.
How much is contract SPE2DB25FN4QB worth?
The government has obligated $3,265 on SPE2DB25FN4QB.
Is contract SPE2DB25FN4QB an order under another contract?
Yes. SPE2DB25FN4QB is a delivery order under SPE2DB22D1200, an indefinite delivery contract.
Was contract SPE2DB25FN4QB competed?
The extent of competition for SPE2DB25FN4QB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award